Ophthalmology Innovation Summit @ AAO 2012 - November 8th - Chicago
The purpose of OIS is to create an ecosystem of clinical, technology and business. Uniting this diverse group of key players in the ophthalmic field fosters innovation and facilitates business transactions. The conference provides a forum for addressing key issues impacting the ophthalmic field and a platform to showcase the most promising private ophthalmic companies. Be among 700+ Innovators/Entrepreneurs, Clinicians, Venture Capitalists, Senior R&D and Biz Dev Execs from Private and Public Companies.
Emmett Cunningham, Jr., MD, PhD, MPH
Clarus Ventures, LLC
Gilbert Kliman, MD
William Link, PhD
Why Attend OIS?
Simple: Meet the most important people in the ophthalmic business.
Hotel / Venue
Chicago Marriott Downtown Magnificent Mile OIS has a reduced room rate of $269 at the Marriott.
Chicago Illinois 60611
OIS has a reduced room rate of $269 at the Marriott.
- Ophthalmic Innovation Year in Review
- Private Device Company Showcase
- Private Pharma Company Showcase
- *NEW: Private Ophthalmology/IT Company Showcase
- Private Funding and Exit Trends
- The Ophthalmology Market – A view from the public sector
- Case Study: “The Road to Success”
- The FDA’s Impact on Ophthalmic Innovation
- OUS Strategy, corneal inlays, retinal prostheses, etc…
- Can Pharma Innovate?
Past Ophthalmology Conference Video Clip
What People Are Saying About OIS @ AAO
"OIS is a unique meeting because it brings together clinical investigators, physician thought leaders, venture capitalists, and executives of both large and small start up companies - all sharing the collective goal of bringing innovative and vision enhancing technologies to market. The format offers a nice mix of executive summary presentations and interactive panel discussion".David F. Chang MD
"Presenting RVO's technology at OIS has attracted a lot of interest from investors, clinicians, and strategic companies. Everyone leaves OIS with a better vision of the future of the ophthalmic industry."Randy Alexander
Chairman, ReVision Optics
"OIS gives industry a forum to interact in a meaningful way with clinicians and private companies which results in excellent synergy. I came away with a deeper understanding of how industry can help."Joseph Markoff MD PhD
Global Director for Scientific Affairs in Ophthalmology, Merck Inc.
"OIS is the merger of ophthalmic ideas and money. I recommend it to everyone."Andy Corley
"The OIS meeting provides a unique opportunity for business professionals and clinician/scientists to share a robust meeting program regarding innovation and commercialization and to develop the relationships necessary for success. The AAO is proud that OIS meets in conjunction with us."David W. Parke II, MD
Executive Vice President & CEO, American Academy of Ophthalmology